Antibiotic Prophylaxis for Acute Variceal Hemorrhage in Cirrhosis

Preferred Antibiotic Regimen

Ceftriaxone 1 g IV once daily should be the first‑line agent for patients with advanced cirrhosis (Child‑Pugh B‑C) and in institutions where quinolone‑resistant organisms are common; it provides coverage of ≈95 % of the bacterial flora typically isolated from cirrhotic patients. 1, 2, 3, 4

Oral norfloxacin 400 mg twice daily can be used in patients who can tolerate oral medication and have less severe liver disease (Child‑Pugh A). 1, 2, 4
Intravenous ciprofloxacin is an option when oral administration is not feasible. 1, 2

Start antibiotics immediately as soon as variceal bleeding is suspected, before diagnostic endoscopy. 3
Continue for a maximum of 7 days, with consideration to stop once bleeding has resolved and vasoactive drugs are discontinued. 1, 2
Rationale for short‑term prophylaxis: bacterial infections develop in >50 % of untreated patients and may already be present in ~20 % at the time of bleeding. 3

Antibiotic prophylaxis in acute variceal hemorrhage is supported by Class I, Level A evidence demonstrating:
- Improved control of bleeding through prevention of infection‑related complications. 4
- Reduced early re‑bleeding rates. 4

Do not delay antibiotic initiation while awaiting endoscopy; start at the first suspicion of bleeding. 3
Do not extend prophylaxis beyond 7 days unless a documented infection warrants continued therapy. 1, 2
Do not rely solely on quinolones in patients with advanced cirrhosis or in regions with high quinolone resistance; ceftriaxone remains the more reliable choice. 1, 3, 4

Combine antibiotic prophylaxis with vasoactive drugs (e.g., octreotide, somatostatin, or terlipressin) initiated simultaneously. 1, 2, 3
Apply a restrictive transfusion strategy, targeting a hemoglobin level of 7–9 g/dL. 1, 3
Perform endoscopic band ligation within 12 hours after hemodynamic stabilization. 1, 2, 3
Continue vasoactive drugs for 3–5 days after endoscopy to further reduce early re‑bleeding risk. 1, 2

Gram-negative aerobic bacteria of enteric origin are the predominant pathogens causing infections in cirrhotic patients with GI hemorrhage, particularly E. coli, Klebsiella pneumoniae, and other Enterobacteriaceae 5, 6
Anaerobic bacteria are not the primary concern in gut translocation during variceal bleeding—the translocation involves aerobic gram-negative organisms from the intestinal lumen 5, 7

The American Association for the Study of Liver Diseases recommends intravenous ceftriaxone 1 g every 24 hours as the antibiotic of choice for cirrhotic patients with GI hemorrhage, particularly those with advanced cirrhosis (Child-Pugh B/C) 6, 8, 9, 10
Ceftriaxone was specifically shown to be more effective than norfloxacin in preventing bacterial infections in patients with advanced cirrhosis and GI hemorrhage, with most prevented infections being gram-negative organisms 5, 7

Ceftriaxone covers approximately 95% of flora commonly isolated in cirrhotic patients with infections 11
No evidence demonstrates superiority of broader anaerobic coverage in preventing infections or improving outcomes in variceal bleeding 5, 6, 8
Antimicrobial stewardship concerns: using broader-spectrum antibiotics like piperacillin-tazobactam without proven benefit increases risk of resistance and C. difficile infection 6, 11

Maximum 7 days of prophylaxis is recommended, with consideration for discontinuation when hemorrhage resolves and vasoactive drugs are stopped 6, 8, 9, 10
The choice should be influenced by local resistance patterns: in settings with high quinolone resistance, ceftriaxone becomes even more important as first-line therapy 5, 9, 10